The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2018 | Association between depth of response and survival in Waldenström’s
Deep responses are associated with longer disease-free survival in a variety of hematologic malignancies; however, this data is limited in Waldenström’s Macroglobulinemia (WM). Jonas Paludo, MD, of the Mayo Clinic, Rochester, MN, discusses the impact of depth of response on disease-free and overall survival in WM. This interview took place at the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA.
